國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 915041      Online Users : 1432
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Collection

    Periodical Articles [412/413]
    Books/Book Section [3/5]
    Conference Papers/Meeting Abstract [49/53]

    Community Statistics


    Item counts issued in 3 years:92(19.53%)
    Items With Fulltext:464(98.51%)

    Download counts of the item
    Download times greater than 0:464(100.00%)
    Download times greater than 100:426(91.81%)
    Total Bitstream Download Counts:138944(2.59%)

    Last Update: 2024-12-01 06:18

    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 326-350 of 471. (19 Page(s) Totally)
    << < 9 10 11 12 13 14 15 16 17 18 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2014-08 Overexpression of ANXA1 confers independent negative prognostic impact in rectal cancers receiving concurrent chemoradiotherapy Tumor Biology. 2014 Aug;35(8):7755-7763.
    2014-05-08 The combination of the prodrugs perforin-CEBPD and perforin-granzyme B efficiently enhances the activation of caspase signaling and kills prostate cancer Cell Death and Disease. 2014 May 8;5:Article number e1220.
    2014-05 Combined therapeutic efficacy of 188Re-liposomes and sorafenib in an experimental colorectal cancer liver metastasis model by intrasplenic injection of C26-luc murine colon cancer cells Molecular and Clinical Oncology. 2014 May;2(3):380-384.
    2014-05 AMACR overexpression is associated with clinical and biological aggressiveness in urothelial carcinomas of the upper urinary tract and urinary bladder European Journal of Cancer. 2014 May;50(Suppl. 4):e35.
    2014-05 MMP11 overexpression: Poor prognosis in patients with urothelial carcinoma of the upper tract and urinary bladder European Journal of Cancer. 2014 May;50(Suppl. 4):e43.
    2014-05 PTP4A3 overexpression predicts clinical aggressiveness in urothelial carcinoma European Journal of Cancer. 2014 May;50(Suppl. 4):e42-e43.
    2014-05 Cyclin-dependent kinase 4 overexpression confers an independent prognosticator of nasopharyngeal carcinoma European Journal of Cancer. 2014 May;50(Suppl. 4):e68.
    2014-05 CSF2 overexpression as a poor prognostic factor in patients with urothelial carcinoma of the upper urinary tract and urinary bladder European Journal of Cancer. 2014 May;50(Suppl. 4):e35-e36.
    2014-05 Overexpression of DPP4 is a poor prognostic factor for patients with urothelial carcinoma of the upper urinary tract and urinary bladder European Journal of Cancer. 2014 May;50(Suppl. 4):e39.
    2014-03-25 Adiponectin enhances intercellular adhesion molecule-1 expression and promotes monocyte adhesion in human synovial fibroblasts PLoS ONE. 2014 Mar 25;9(3):Article number e92741.
    2014-03 Overexpression of stathmin 1 confers an independent prognostic indicator in nasopharyngeal carcinoma Tumor Biology. 2014 Mar;35(5):2619-2629.
    2014-02 Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging Cancer Research. 2014 Feb;74(3):896-907.
    2014-02 CDCA5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tract and urinary bladder Modern Pathology. 2014 Feb;27(Suppl. 2):220A.
    2014-02 HOXC6 overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma Modern Pathology. 2014 Feb;27(Suppl. 2):331A.
    2014-02 SLC14A1 down-regulation is associated with poor clinical outcome in patients with urothelial carcinoma of upper urinary tracts and urinary bladder Modern Pathology. 2014 Feb;27(Suppl. 2):245A.
    2014-02 Characterization of the clinical, biological, and therapeutic relevance of EZH2 overexpression in myxofibrosarcoma Modern Pathology. 2014 Feb;27(Suppl. 2):22A.
    2014-02 CDCA5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tract and urinary bladder Laboratory Investigation. 2014 Feb;94(S1):220A.
    2014-02 SLC14A1 down-regulation is associated with poor clinical outcome in patients with urothelial carcinoma of upper urinary tracts and urinary bladder Laboratory Investigation. 2014 Feb;94(S1):245A.
    2014-02 HOXC6 overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma Laboratory Investigation. 2014 Feb;94(S1):331A.
    2014-02 Characterization of the clinical, biological, and therapeutic relevance of EZH2 overexpression in myxofibrosarcoma Laboratory Investigation. 2014 Feb;94(S1):22A.
    2014-01 Deficiency in expression and epigenetic DNA Methylation of ASS1 gene in nasopharyngeal carcinoma: Negative prognostic impact and therapeutic relevance Tumor Biology. 2014 Jan;35(1):161-169.
    2013-12 Novel strategies for the treatment of chondrosarcomas: Targeting integrins BioMed Research International. 2013 Dec;2013:Article number 396839.
    2013-11 The E2F transcription factor 1 transactives Stathmin 1 in hepatocellular carcinoma Annals of Surgical Oncology. 2013 Nov;20(12):4041-4054.
    2013-10 STMN1 overexpression as a poor prognostic factor in patients with Nasopharyngeal Carcinoma International Journal of Radiation Oncology Biology Physics. 2013 Oct;87(2, Supple. 1):S666-S667.
    2013-08-01 Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression Cell. 2013 Aug 1;154(3):556-568.

    Showing items 326-350 of 471. (19 Page(s) Totally)
    << < 9 10 11 12 13 14 15 16 17 18 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback